Ventolin Rotacaps

Hyperkalemia, Acute Bronchitis, Pneumonia + 18 more

Treatment

9 FDA approvals

20 Active Studies for Ventolin Rotacaps

What is Ventolin Rotacaps

Salbutamol

The Generic name of this drug

Treatment Summary

Salbutamol is a medication used to treat asthma and COPD. It works by activating beta2-receptors in the lungs to reduce symptoms such as wheezing, coughing, and difficulty breathing. Salbutamol is a mix of two different forms (R- and S-isomers), with the R-isomer being more effective. A more expensive, single R-isomer version of the drug (Levalbuterol) is also available, but salbutamol is more commonly prescribed. Salbutamol is used to treat both acute episodes of bronchospasm and to prevent exercise-

Proair HFA

is the brand name

image of different drug pills on a surface

Ventolin Rotacaps Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Proair HFA

Salbutamol

1981

314

Approved as Treatment by the FDA

Salbutamol, also known as Proair HFA, is approved by the FDA for 9 uses like Chronic Obstructive Pulmonary Disease and Bronchospasm, Exercise-Induced .

Chronic Obstructive Pulmonary Disease

Used to treat Chronic Obstructive Pulmonary Disease (COPD) in combination with Ipratropium

Bronchospasm, Exercise-Induced

Bronchial Spasm

prophylaxis of Exercise-induced bronchospasm

Bronchospasm

Bronchodilator Agents

Used to treat need of more than one bronchodilator in combination with Ipratropium

Asthma, Exercise-Induced

prophylaxis of Bronchospasm

Exercise-Induced Bronchospasm

Effectiveness

How Ventolin Rotacaps Affects Patients

Salbutamol (also known as albuterol) is a medication used to open up airways and relieve breathing problems like asthma. It works by stimulating beta-1 and beta-2 receptors in the body, which helps to relax the muscles in the lungs. Side effects can include trembling muscles, lower blood pressure, and changes in insulin and blood sugar levels. It can also lower potassium levels in the blood. Salbutamol is similar to another medication called terbutaline, but the version of salbutamol called levalbuterol is thought to have fewer side effects.

How Ventolin Rotacaps works in the body

Salbutamol works by relaxing the muscles in the airways, which allows more air to flow through. It does this by activating beta2-adrenergic receptors on the airway muscles, which triggers a series of chemical reactions that result in muscle relaxation. Salbutamol is especially useful because it is more effective on the airways than similar drugs and has fewer side effects on the heart. After inhalation, it usually takes 5-15 minutes for airway relaxation to begin, and the effects can last for up to 6 hours.

When to interrupt dosage

The suggested quantity of Ventolin Rotacaps is founded on the diagnosed condition, including Bronchodilator Agents, Emphysema and Wheezing. The amount of dosage changes, in line with the technique of administration featured in the table beneath.

Condition

Dosage

Administration

Pneumonia

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

prophylaxis of Bronchospasm

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Emphysema

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Respiratory Tract Infections

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Asthma, Exercise-Induced

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Airway secretion clearance therapy

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

excess mucus or phlegm

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Asthma

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Acute Bronchitis

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Bronchitis, Chronic

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Asthma

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Influenza

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Bronchodilation

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Bronchial Spasm

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Bronchitis

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Hyperkalemia

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Asthma

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Respiratory Sounds

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Chronic Obstructive Pulmonary Disease

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Bronchospasm, Exercise-Induced

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid - Intravenous, Liquid - Intramuscular, Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Liquid, Liquid - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Aerosol, spray - Oral, Spray, metered, Aerosol, spray, Spray, Spray - Oral

Warnings

There are 20 known major drug interactions with Ventolin Rotacaps.

Common Ventolin Rotacaps Drug Interactions

Drug Name

Risk Level

Description

Hydroxyzine

Major

The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Hydroxyzine.

Mobocertinib

Major

The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Mobocertinib.

Ziprasidone

Major

The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Ziprasidone.

1-benzylimidazole

Minor

The risk or severity of hypertension can be increased when Salbutamol is combined with 1-benzylimidazole.

2,5-Dimethoxy-4-ethylamphetamine

Minor

The risk or severity of hypertension can be increased when Salbutamol is combined with 2,5-Dimethoxy-4-ethylamphetamine.

Ventolin Rotacaps Toxicity & Overdose Risk

Taking too much Albuterol can lead to symptoms such as seizures, chest pain, high or low blood pressure, very fast heartbeat, nervousness, headaches, tremors, muscle cramps, dry mouth, palpitations, nausea, dizziness, fatigue, restlessness, difficulty sleeping, high blood sugar, low potassium, and acidosis. There have also been reports of birth defects in animals exposed to Albuterol during pregnancy. Nursing mothers should talk to their doctor before using Albuterol. It is not recommended for young children under the age of 4 due to lack of research. Elderly patients should start

image of a doctor in a lab doing drug, clinical research

Ventolin Rotacaps Novel Uses: Which Conditions Have a Clinical Trial Featuring Ventolin Rotacaps?

383 active clinical trials are currently in progress to assess the potential of Ventolin Rotacaps in alleviating Respiratory Tract Infections, Asthma and Chronic Obstructive Pulmonary Disease (COPD).

Condition

Clinical Trials

Trial Phases

prophylaxis of Bronchospasm

0 Actively Recruiting

Influenza

29 Actively Recruiting

Not Applicable, Phase 3, Phase 4, Phase 2, Phase 1

Asthma

97 Actively Recruiting

Phase 1, Phase 4, Not Applicable, Early Phase 1, Phase 2, Phase 3

Chronic Obstructive Pulmonary Disease

79 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Phase 3, Phase 4

Bronchospasm, Exercise-Induced

0 Actively Recruiting

Hyperkalemia

4 Actively Recruiting

Phase 3, Phase 2, Phase 1, Not Applicable

Bronchitis, Chronic

6 Actively Recruiting

Phase 2, Not Applicable, Phase 4

excess mucus or phlegm

0 Actively Recruiting

Bronchodilator Agents

0 Actively Recruiting

Pneumonia

18 Actively Recruiting

Not Applicable, Phase 2, Early Phase 1, Phase 4

Bronchial Spasm

0 Actively Recruiting

Asthma

10 Actively Recruiting

Phase 2, Not Applicable

Airway secretion clearance therapy

0 Actively Recruiting

Respiratory Sounds

0 Actively Recruiting

Asthma

1 Actively Recruiting

Phase 4

Asthma, Exercise-Induced

0 Actively Recruiting

Emphysema

6 Actively Recruiting

Phase 2, Not Applicable, Early Phase 1

Bronchitis

0 Actively Recruiting

Acute Bronchitis

6 Actively Recruiting

Not Applicable, Phase 3, Early Phase 1, Phase 4

Bronchodilation

0 Actively Recruiting

Ventolin Rotacaps Reviews: What are patients saying about Ventolin Rotacaps?

5

Patient Review

6/7/2009

Ventolin Rotacaps for Asthma

This treatment is really easy to use, which I appreciate.

5

Patient Review

9/16/2008

Ventolin Rotacaps for Bronchitis

I thought the rotacaps inhaler was easy to use and much better for you than other propellant-based inhalers.

5

Patient Review

10/26/2011

Ventolin Rotacaps for Asthma

This treatments is very easy to use, which I appreciate.

Patient Q&A Section about ventolin rotacaps

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How do you take Ventolin Rotacap?

"Adults: 200-400 micrograms of Rotacaps inhaled 3 or 4 times daily via Rotahaler. The maximum dose in 24 hours is 12 Rotacaps. Children (to 12 years): 200 micrograms of Rotacaps inhaled 3 or 4 times daily via Rotahaler. The maximum dose in 24 hours is 6 Rotacaps."

Answered by AI

Is Rotacaps a steroid?

"Foracort 200 Rotacap is a combination of two medicines: Formoterol and Budesonide. Formoterol is a long-acting bronchodilator which works by relaxing the muscles in the airways and widens the airways. Budesonide is a steroid."

Answered by AI

Is Ventolin tablet a steroid?

"Ventolin does not contain steroids. The active ingredient, albuterol, is a bronchodilator that relaxes the smooth muscle in the airways, allowing air to flow in and out of the lungs more easily."

Answered by AI

What is the side effects of Rotacaps inhaler?

"headache, nausea, feeling shaky or tense, heart beating faster than usual, feeling 'warm', mouth or throat irritation"

Answered by AI

Clinical Trials for Ventolin Rotacaps

Have you considered Ventolin Rotacaps clinical trials?

We made a collection of clinical trials featuring Ventolin Rotacaps, we think they might fit your search criteria.
Go to Trials
Image of Seattle Children's Hospital in Seattle, United States.

Follow-Up Strategies for Children With Medical Complexity

1 - 16
All Sexes
Seattle, WA

Children with medical complexity often receive a recommendation to see an outpatient clinician soon after leaving the hospital. It is uncertain whether every child needs this routine visit or whether follow-up can be guided by the family's concerns and the child's recovery. AFTERCARE is a multicenter pilot randomized trial comparing these two follow-up recommendations for children hospitalized with an acute infection. Families will be assigned by chance to receive either a recommendation to arrange follow-up with their usual outpatient clinician within seven days or a recommendation to seek follow-up if the child is not improving as expected or new concerns arise. Families in both groups may seek medical care whenever needed. The study will assess recruitment, follow-up data collection, delivery of the recommendations and acceptability. Caregiver surveys and medical record review will also describe outpatient visits and hospital returns. This pilot will inform the design of a larger trial, and is not designed to establish that the strategies are equally safe or effective.

Waitlist Available
Has No Placebo

Seattle Children's Hospital

Nassr Nama, MD, MSc

Image of Ontario Tech University in Oshawa, Canada.

Temperature & Humidity Exposure for Asthma

11 - 18
All Sexes
Oshawa, Canada

The goal of this clinical study is to learn how different temperature and humidity conditions affect breathing, lung function, exercise capacity, symptoms, and other physical responses in children and youth aged 11 to 18 years with asthma, compared with age- and sex-matched children and youth without asthma. The main questions it aims to answer are: * How do different temperature and humidity conditions affect lung function, breathing symptoms, exercise capacity, and physiological responses in children and youth with asthma? * Do children and youth with asthma respond differently to these environmental conditions than children and youth without asthma? * Do sex and gender influence these responses? Researchers will compare children and youth with asthma to age- and sex-matched children and youth without asthma to see if temperature and humidity exposures have different effects on breathing, exercise performance, symptoms, and physiological responses. Participants will: * Attend two study visits in a climate-controlled chamber. * Be exposed to hot, cold, and varying humidity conditions for short periods of time. * Complete breathing tests and exercise testing before, during, and after each exposure. * Have symptoms, physical activity, and physiological responses monitored throughout the study.

Waitlist Available
Has No Placebo

Ontario Tech University

Image of Rocky Mountain Regional VA Medical Center, Aurora, CO in Aurora, United States.

Low-Dose CT for Lung Cancer Screening

50 - 80
All Sexes
Aurora, CO

Lung cancer screening with low-dose chest computed tomography (CT) is currently recommended for high-risk individuals who are 50 to 80 years old, have smoked cigarettes for at least 20 pack-years, and currently smoke or quit smoking within the past 15 years. In a prospective cohort at Nashville, Denver, Louisville, Chicago, Kansas City, Salisbury and Seattle Veteran Affairs medical centers, the investigators will evaluate the detection of lung cancer using an expanded screening eligibility criteria based on Veterans' personal and service-related exposures compared to standard of care criteria. Screening a larger population will increase the number of lung nodules needing clinical management and these nodules may or may not be cancer. In a population of Veterans with positive screenings at Nashville, the investigators will also validate a combination biomarker-based approach to manage screen-detected lung nodules to reduce time to lung cancer diagnosis and use of invasive procedures. This study will also convene a Veteran Community Advisory Board and interview Veterans to better understand their thoughts about lung cancer screening and preferences for outreach and engagement.

Waitlist Available
Has No Placebo

Rocky Mountain Regional VA Medical Center, Aurora, CO (+6 Sites)

Jennifer A Lewis, MD MS MPH

Bristol-Myers Squibb

Have you considered Ventolin Rotacaps clinical trials?

We made a collection of clinical trials featuring Ventolin Rotacaps, we think they might fit your search criteria.
Go to Trials
Image of Children's Hospital Los Angeles in Los Angeles, United States.

Wearable Stethoscope for Childhood Asthma

4 - 17
All Sexes
Los Angeles, CA

The goal of this clinical trial is to evaluate a prototype wearable stethoscope designed to record lung sounds and assess asthma control in children and adolescents with asthma aged 4 to 17 years who are able to perform spirometry. The study aims to determine whether the prototype wearable stethoscope can accurately detect clinically meaningful changes in lung sounds associated with asthma control and response to bronchodilator treatment. The main questions it aims to answer are: * Does the prototype wearable stethoscope demonstrate agreement with recordings obtained from commercially available Thinklabs One Digital Stethoscopes in identifying normal and abnormal lung sounds? * Are lung sounds detected by the prototype wearable stethoscope associated with asthma symptom control as measured by the Childhood Asthma Control Test (cACT) or Asthma Control Test (ACT) Researchers will compare recordings obtained from the prototype wearable stethoscope with recordings obtained from FDA-cleared Thinklabs One Digital Stethoscopes to evaluate the prototype device's ability to detect abnormal lung sounds and changes in lung sounds following bronchodilator treatment.

Waitlist Available
Has No Placebo

Children's Hospital Los Angeles

Roberta Kato, MD

Have you considered Ventolin Rotacaps clinical trials?

We made a collection of clinical trials featuring Ventolin Rotacaps, we think they might fit your search criteria.
Go to Trials